Nucleonics, Inc

14 Spring Mill Dr,
Malvern,
PA 19355
United States of America
Tel: 610 296 0722
Fax: 610 296 3122

Nucleonics Inc., develop, manufacture and market products based upon proprietary RNAi technologies

Further Information: http://nucleonicsinc.com/

Related news from our archive

First Ever Test of Gene Silencing Therapy for Hepatitis B
California Pacific Medical Center in San Francisco claims to have become the first medical research institution in the world to use a gene silencing therapy to treat Hepatitis B.

Nucleonics Receives FDA Clearance to Begin Phase 1 Trial of eiRNA Therapy
The Company to start Phase 1 human safety study of its investigational eiRNA therapy for the treatment of chronic hepatitis B infection.